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http://dx.doi.org/10.1016/j.bpj.2012.09.026The actin cortex below the plasma membrane of mammalian
cells is essential for maintenance of cell shape and for cell
movement. This cortex has also been found to play an essen-
tial role in the replication process of a number of viruses
including West Nile virus (1), respiratory syncytial virus
(2), influenza (3), and vaccinia virus (4). Additionally, actin
has been found to play a central role in the assembly and
budding of HIV-1 (5) whereas Marburg virus has been
shown to use actin-enriched filopodia to exit the host
cell (6). Actin has also been found to be packaged into
Ebola-virus-like particles (VLPs) (7). Ebola virus, which
causes severe hemorrhagic fever, harbors a single-stranded
negative-sense RNA genome encoding seven proteins. Of
these seven proteins, VP40 is the most abundantly expressed
and has been found to play a central role in the budding of
the virus from the plasma membrane (8). Whereas actin has
been found in Ebola VLPs (7), the role of actin in Ebola
VP40 assembly is still seemingly unknown. Here, we have
used Raster image correlation spectroscopy (RICS) (9)
and three-dimensional single-particle tracking (see Fig. S1
in the Supporting Material) (10) to investigate the dynamics
of Ebola VP40 and actin. We report that preassembled VLPs
(pVLPs) of Ebola VP40 require actin for directed movement
and assembly.
Ebola VP40 has been demonstrated to colocalize with
actin and actin is found in VP40 VLPs (7), suggesting an
important role for actin in the replication cycle of the virus.
To confirm the colocalization between VP40 and actin in
HEK293 and CHO-K1 cells, we used confocal microscopy
to examine the distribution of EGFP-VP40 and mCherry-
actin. EGFP-VP40 and mCherry-actin displayed colocaliza-
tion at the plasma membrane of HEK293 and CHO-K1 cells
(see Fig. S2 A), which was markedly reduced in response totreatment with LAT-A (see Fig. S2 B and Fig. S3 A), an actin
polymerization inhibitor. VP40 plasma membrane localiza-
tion was not disrupted by LAT-A treatment (not unexpected,
as VP40 is a lipid-binding protein (11) where high affinity
for the PM drives its cellular localization (E. Adu-Gyamfi
and R. V. Stahelin, unpublished)). To test whether this
VP40-actin interaction is important to viral egress, we de-
tected EGFP-VP40 with an anti-EGFP antibody used to
measure VLPs formed from cells expressing EGFP-VP40.
This was also performed to assess the effect of pharmaco-
logical treatment on EGFP-VP40-expressing cells with
LAT-A or with the microtubule polymerization inhibitor
nocodazole (see Fig. S3 B). LAT-A treatment led to a signif-
icant reduction in VLP formation whereas nocodazole did
not display detectable effects.
To test whether the VP40 and actin are engaged
in synchronized movement, we performed time-lapse
imaging in both the green and red channels. We observed
that the pVLPs move with actin fibers extending from the
plasma membrane (see Movie S1 in the Supporting
Material). The movement was rapid, and caused smaller
particles to merge into larger filamentous forms. To further
demonstrate that the motion of actin and VP40 spatially
overlapped, we used RICS to obtain correlation maps
of EGFP-VP40 and mCherry-actin (Fig. 1). The spatial
cross-correlation map indicated significant overlap of
VP40 and actin movement (Fig. 2, A–C) at the plasma
membrane (Fig. 1 and see Fig. S6), but not in the cytosol
FIGURE 1 EGFP-VP40 and mCherry-actin
RICS analysis at the membrane. (A) HEK293
cells expressing EGFP-VP40 and mCherry-
actin were imaged for 100 frames at 256  256
pixels. (White scale bar ¼ 2 mm.) (B) Average
intensity image of EGFP-VP40 across the 100
collected frames. (Pink box) Used to select
a region of interest to yield the (C) average
EGFP-VP40 intensity image. (D) Average inten-
sity image of mCherry-actin taken for 100
frames at 256  256 pixels was used to select
the same region of interest as in panel B (pink
box) to yield the (E) average intensity image of
the mCherry-actin signal in this region. (F)
The two-dimensional spatial cross-correlation
analysis of panels C and E demonstrates sig-
nificant cross-correlation of VP40 and actin
signals.
L42 Biophysical Letters(see Fig. S5 and Fig. S7). In contrast, EGFP-VP40 and
mCherry-a-tubulin (see Fig. S8, Fig. S9, and Fig. S10)
displayed no significant spatial cross-correlation at the
plasma membrane (Fig. S11) or other regions of the cell
(see Fig. S12), supporting the VLP egress data where inhi-
bition of microtubule polymerization did not influence
viral egress.
To test whether the motion of the pVLPs is directed by
actin, we applied the three-dimensional orbital tracking
method first introduced by Levi et. al. (10). Tracking of
isolated particles (Fig. 3 A) in five different cells allowed
determination of the pVLPs trajectories (Fig. 3 D), which
suggested that the VP40 particles undergo a directed
motion. To verify this, we plotted the mean-square dis-
placement (MSD) curves for the pVLPs (Fig. 3 C), which
confirmed the trajectory was characteristic of directed
motion. Analysis of the intensity profile of the dynamic
VP40 particles suggested that the intensity of the particleFIGURE 2 Three-dimensional RICS correlationmaps of VP40 and ac
(B) mCherry-actin (Fig. 1 and see Fig. S6 in the Supporting Material) R
is observed for EGFP-VP40 and mCherry-actin at the plasma memb
Biophysical Journal 103(9) L41–L43changes with respect to time. Bleaching is expected if the
molecule is exposed to the laser beam for an extended
period of time; however, an increase in intensities was
observed along the trajectory of the green channel due to
addition of VP40 molecules. This suggests that the move-
ment of the particles along actin fibers promote multi-
merization and maturation of the pVLPs. When actin
polymerization was inhibited in four different cells with
LAT-B, the rapid movement (see Fig. S13) and the directed
trajectories of the pVLPs were lost (Fig. 3, E and F). This
was reflected in a change from directed motion to move-
ment indicative of random then constrained diffusion
(Fig. 3, E and F).
Taken together, our findings demonstrate that the move-
ment of the pVLPs is driven by actin. Analysis of the pVLPs
trajectories also suggests that the motion of pVLPs on actin
enables further addition of VP40 molecules. These find-
ings raise important questions regarding contemporarytin cross-correlate at the plasmamembrane. (A) EGFP-VP40 and
ICS autocorrelation functions. (C) Appreciable cross-correlation
rane.
FIGURE 3 Actin directs the
movement of VP40 particles.
HEK293 cells transfected with
EGFP-VP40 were imaged with an
electronic zoom of 2000 mV, cor-
responding to 72 nm/pixel in
both X and Y. (A) An isolated
and representative VP40 particle
(highlighted by white box, inset)
was tracked as described in the
Supporting Material. (B) Intensity
profile of the pVLP in A demon-
strates increases in EGFP-VP40
intensity along the trajectory. (C)
MSD of the pVLP, which follows
a ballistic motion with a velocity
of 0.067 5 0.01 mm2 s1. (D) The
three-dimensional trajectory of
the particle shown in panels A–C.
(E) MSD curve of VP40 particles
yields random then constrained
diffusion after LAT-B treatment
with a mean velocity of 0.017 5
0.006 mm2 s1 (p < 0.001). (F)
Three-dimensional trajectory of
the same particle shown in panel
E displays a random then con-
strained diffusion.
Biophysical Letters L43understanding of Ebola assembly and egress. VP40 lacks a
consensus actin-binding motif, suggesting an adaptor pro-
tein such as an actin motor protein may function in this
process. For instance, Myo10 has been found to be essential
to Marburg virus release (6); however, Marburg VP40-
Myo10 direct interactions were not observed, suggesting
other cellular adaptor proteins may function in this process.
Given the pathogenic nature of the Ebola virus and the
necessity of VP40 to the assembly and egress of the virus
(8), the VP40-actin coordination represents, to us, a novel
target for therapeutic development.SUPPORTING MATERIAL
Materials and Methods, thirteen figures, and one movie are available at
http://www.biophysj.org/biophysj/supplemental/S0006-3495(12)01064-8.ACKNOWLEDGMENTS
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